|Articles|January 18, 2021
Application Note: Analysis of Camelid Single-Domain Antibodies Using Agilent AdvanceBio SEC 120 Å 1.9 µm and AdvanceBio HIC Columns
Author(s)Agilent
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
2
Distribution Resilience: Meeting Global Demand and Delivering Faster, More Reliable Service
3
Scaling Manufacturing of Novel Therapies
4
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
5
